Association of Adiponectin Receptor (Adipo-R1/-R2) Expression and Colorectal Cancer |
Ayyildiz, Talat
(Department of Gastroenterology, Medical Faculty, Ondokuz Mayis University)
Dolar, Enver (Department of Gastroenterology, Medical Faculty, Uludag University) Ugras, Nesrin (Department of Pathology, Medical Faculty, Uludag University) Adim, Saduman Balaban (Department of Pathology, Medical Faculty, Uludag University) Yerci, Omer (Department of Pathology, Medical Faculty, Uludag University) |
1 | Ayyildiz T, Dolar E, Ugras N, et al (2014). Lack of any prognostic relationship between adiponectin receptor (Adipo R1/R2) expression for early/advanced stage gastric cancer. Asian Pac J Cancer Prev, 15, 4711-16. 과학기술학회마을 DOI |
2 | Barresi V, Tuccari G, Barresi G (2009a). Adiponectin immunohistochemical expression in colorectal cancer and its correlation with histological grade and tumour microvessel density. Pathology, 41, 533-8. DOI |
3 | Barresi V, Grosso M, Giuffre G, Tuccari G, Barresi G (2009b). The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol, 62, 705-9. DOI |
4 | Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA, 101, 2476-81 DOI ScienceOn |
5 | Byeon JS, Jeong JY, Kim MJ, et al (2010). Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer, 127, 2758-67. DOI ScienceOn |
6 | Chen MW, Ye S, Zhao LL, et al (2012). Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol, 29, 3129-35. DOI ScienceOn |
7 | Cnop M, Havel PJ, Utzschneider KM, et al (2003). Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46, 459-69. |
8 | Colussi D, Brandi G, Bazzoli F, Ricciardiello L (2013). Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci, 14, 16365-85. DOI |
9 | Dal Maso L, Augustin LS, Karalis A, et al (2004). Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89, 1160-3. DOI ScienceOn |
10 | Dalamaga M, Diakopoulos KN, Mantzoros CS (2012). The role of adiponectin in cancer: a review of current evidence. Endocr Rev, 33, 547-94. DOI |
11 | Dancey JE (2002). Clinical development of mammalian target of rapamycin inhibitors. Hematol Oncol Clin North Am, 16, 1101-14 . DOI |
12 | Fukumoto J, Otake T, Tajima O, et al (2008). Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci, 99, 781-6. DOI |
13 | Goldfine AB, Kahn CR (2003). Adiponectin: linking the fat cell to insulin sensitivity. Lancet, 362, 1431-2. DOI ScienceOn |
14 | Gonullu G, Kahraman H, Bedir A, et al (2010). Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis, 25, 205-12. DOI ScienceOn |
15 | Ishikawa M, Kitayama J, Kazama S, et al (2005). Plasma adiponectin and gastric cancer. Clin Cancer Res, 11, 466-72. |
16 | Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8. 과학기술학회마을 DOI ScienceOn |
17 | Ho GY, Wang T, Gunter MJ, et al (2012). Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res, 72, 3029-37. DOI |
18 | Huang S, Houghton PJ (2003). Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol, 3, 371-77. DOI ScienceOn |
19 | Joshi RK, Lee SA (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405. 과학기술학회마을 DOI ScienceOn |
20 | Kadowaki T, Yamauchi T, Kubota N, et al (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest, 116, 1784-92. DOI ScienceOn |
21 | Kamada Y, Matsumoto H, Tamura S, et al (2007). Hypoadiponectinemia accelerates hepatic tumor formation in nonalcoholic steatohepatitis mouse model. J Hepatol, 47, 556-64. DOI |
22 | Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G (2002). Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care, 25, 971- 6. DOI ScienceOn |
23 | Kelesidis I, Kelesidis T, Mantzoros CS (2006). Adiponectin and cancer: a systematic review. Br J Cancer. 94, 1221-5. DOI ScienceOn |
24 | Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89,1102-7. DOI ScienceOn |
25 | Kojima S, Kojima S, Maruyoshi H, et al (2011). Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque. Int J Cardiol, 147, 371-6. DOI |
26 | Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-81. DOI ScienceOn |
27 | Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006). Serum adiponectin is not associated with risk of CRC. Cancer Epidemiol Biomarkers Prev, 15, 401-2. DOI ScienceOn |
28 | Matsuzawa Y, Shimomura I, Kihara S, et al (2003). Importance of adipocytokines in obesity-related diseases. Horm Res, 3, 56-9. |
29 | Michalakis K, Williams CJ, Mitsiades N, et al (2007). Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev, 16, 308-13. DOI ScienceOn |
30 | Moore LL, Bradlee ML, Singer MR, et al (2004). BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord, 28, 559-67. DOI ScienceOn |
31 | Murphy TK, Calle EE, Rodriguez C et al (2000). Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol, 152, 847-54. DOI ScienceOn |
32 | Oldham S, Hafen E (2003). Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol, 13, 79-85. DOI ScienceOn |
33 | Philp AJ, Campbell IG, Leet C, et al (2001). The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res, 61, 7426-29. |
34 | Otake S, Takeda H, Suzuki Y, et al (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11, 3642-6. DOI ScienceOn |
35 | Ouchi N, Kihara S, Arita Y, et al (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100, 2473-6. DOI ScienceOn |
36 | Ouchi N, Kihara S, Arita Y, et al (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 103, 1057-63. DOI ScienceOn |
37 | Rodrigues VS, Milanski M, Fagundes JJ, et al (2012). Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease. Clin Exp Immuno, 170, 358-64. DOI |
38 | Saxena A, Baliga MS, Ponemone V, et al (2013). Mucus and adiponectin deficiency: role in chronic inflammation-induced colon cancer. Int J Colorectal Dis, 28,1267-79 DOI |
39 | Siegel R, DeSantis C, Virgo K, et al (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin , 62:220-41. DOI |
40 | Vogt PK (2001). PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med, 7, 482-4. DOI |
41 | Wei EK, Giovannucci E, Fuchs CS, Willet WC, Mantzoros CS (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94. DOI ScienceOn |
42 | Yang WS, Lee WJ, Funahashi T, et al (2002). Plasma adiponectin levels in overweight and obese Asians. Obes Res, 10, 1104-10. DOI ScienceOn |
43 | Williams CJ, Mitsiades N, Sozopoulos E, et al (2008). Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr Relat Cancer, 15, 289-99. DOI |
44 | Wolpin BM, Mayer RJ (2008). Systemic treatment of colorectal cancer. Gastroenterol, 134, 1296-10. DOI ScienceOn |
45 | Yamauchi T, Kamon J, Ito Y, et al (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-9. DOI ScienceOn |
46 | Yoneda K, Tomimoto A, Endo H, et al (2008). Expression of adiponectin receptors, Adipo-R1 and Adipo-R2, in normal colon epithelium and colon cancer tissue. Oncol Rep, 20, 479-83. |